The cannabis industry celebrated its favorite holiday with 420 and New Jersey opened its doors to the first recreational cannabis sale. The hemp genetics section of the supply chain continues to experience a strong 2022, with seed and clone prices up 70% year over year. The industry continues to navigate financial, logistical, agricultural, political, and supply chain-based issues with more farmers and acres being planted in the southern states. We believe this is the driving force behind increased genetics prices this year.

With the northeastern states bringing recreational cannabis programs online, further support for the hemp industry will follow. States with legal cannabis programs tend to have higher CBD consumption and provide more support to their hemp programs from a government level. The perfect example is New York recently expressing that it will allow provisional marijuana licenses to hemp cultivators already licensed in the state. This essentially provides a lifeline to struggling CBD companies and helps the state shore up any potential inventory shortages that could force consumers back to the legacy market. Legal cannabis will no doubt be good news for operators in states currently lacking one.

Kellen Finney, Eighth Revolution

Editors’ Note: This is an excerpt from our Monthly Playbook. If you would like to read the full monthly playbook and join the thousands of others you can sign up below.

Share and Enjoy !

laptop-img
Get In touch With Us

Action-Oriented problem solvers ready to go

One Report Once a Month Everything you Need to know

From executive-level strategy to technical know-how, our actionable insights keep you ahead of the pack!

Influencing Culture with Industry Leading Brands

On why he made the leap from Clorox to Cannabis to join the Parent Company

Six months ago, I was sitting at my desk at Clorox managing supply issues during a worldwide pandemic. You can probably say my job was pretty cake as the leader of global sales for a disinfecting products company.

The purpose piece was the reason why I came over. Other than that, I would’ve never, never left my opportunity at Clorox. I’ve been with the organization for 22 years, and you develop a bit of comfort. I was part of the DNA of the company. I’d been around for a large part of that hundred years and was shaping culture as a company. I had a lot of freedom to be who I am and there’s a lot of covers that comes with that. But this was just too interesting an opportunity to pass up for sure.

What were the first days like leading a vertically integrated company?

Observation. On, day two, I got a chance to meet with folks from Jay-Z’s team to really understand the quality that’s expected from Monogram and the rules of engagement with them.

On day three, I was out on a delivery route with my delivery drivers to better understand that part of the operations. I spent the better part of the week in our operations to understand cultivation. We call it, the back-end work that goes into developing a product and spent some time in our dispensaries next to our budtenders.

And they’re making recommendations to folks as they enter our location. So, I really spent time across the entire ecosystem just trying to observe and learn. I think one of my jobs is to serve as a general manager for the business, say, looking at all the puts and takes of building a great organization, that includes seeing everything from seed. So, my job is really to just listen.

Troy Datcher, CEO of The Parent Company

you know, one of the things that we’ve seen over the last past year for us is a mainstreaming location and where our dispensary is. You know, I’ve got a couple of locations now that are in parking lots of big retailers like Costco. I’ve got some locations that we had at the very beginning of legalization in California that looked like you’re going down an industrial road to do a drug deal. Right? It feels like, like, why would I go down this road? Like it is only to do a drug deal.

And so, the more that we can actually mainstream it, I think, the American sentiment is already there. It’s about how we catch up with zoning laws and all these other things. Get those things fixed so that we can bring the center closer to the reality.

If you could sum up your experience in a main takeaway or lesson learned to pass onto the next generation?

Take the risk. I’d say don’t be afraid to make the leap

*** The following transcript is AI generated and some words have been removed for spacing. Please listen to the epsiode for full context.

Editors’ Note: This is an excerpt from our Monthly Playbook. If you would like to read the full monthly playbook and join the thousands of others you can sign up below.

Share and Enjoy !

laptop-img
Get In touch With Us

Action-Oriented problem solvers ready to go

One Report Once a Month Everything you Need to know

From executive-level strategy to technical know-how, our actionable insights keep you ahead of the pack!

Reading through headlines this month you can feel the change in the air with several companies posting double-digit percent increases in revenue and several large companies posting double-digit percent decreases in revenue. The CBD and minor cannabinoid markets experienced a relatively stable month, especially when compared to the overall global securities market. As with all other agricultural-based industries, operators should at least be aware of the global fertilizer market landscape, as current unrest in Europe will drive raw ingredient prices higher resulting in higher operating expenses downstream. The cannabis industry continues to be a battlefield on the west coast and a brand new market on the east coast. It will be exciting to observe how quickly the East Coast markets mature and if they make the same mistakes the West coast did when bringing markets online. We look forward to providing you with consistent reliable information to navigate both the established and emerging markets

Kellen Finney, Eighth Revolution

Editors’ Note: This is an excerpt from our Monthly Playbook. If you would like to read the full monthly playbook and join the thousands of others you can sign up below.

Share and Enjoy !

laptop-img
Get In touch With Us

Action-Oriented problem solvers ready to go

One Report Once a Month Everything you Need to know

From executive-level strategy to technical know-how, our actionable insights keep you ahead of the pack!

The cannabis thesis continues to validate what most Americans already feel. Americans are ready for Cannabis legalization. 70% of Americans support cannabis legalization. 7 out of 10! That number is staggering when you break down how divided we are over some, let’s call it, basic human rights issues.

Here are signs the thesis is strengthening: New Jersey adult use is live. New York is meandering toward online. Rhode Island just legalized. Maryland and Pennsylvania are all trending in the same direction. This is what substantial industry progress looks like to the outside industry. The outside industry believes the Cannabis industry is thriving. When you look under the hood it tells a different story. Internally, the Cannabis industry is fatigued and it’s becoming more evident and harder to ignore.

California Cannabis Operators are fighting to survive. California is the largest domestic market—is this the thriving perspective that outside industry sees happening? Where is the complete disconnect between inside and out? Cannabis isn’t the only industry fighting exhaustion or burnout. Burnout is happening in other industries. Post pandemic has nurses reconsidering their place in the industry. According to Mckinsey, “1 in 3 nurses plan on leaving within the year.” 1 in 3!

While the Cannabis industry faces different obstacles the same constant applies. Exhaustion from industry-related challenges, pandemic, markets being bloodied, war, potential recession, supply chain, the list is hard to even write. Overcoming all of these obstacles on a regular basis is exhausting.

Is this the next phase of industry maturity or just another obstacle the Cannabis industry needs to overcome? Exhaustion is a byproduct of continuing to fight forward on all fronts. What needs to happen? Relief in some capacity. The industry could use a victory such as safe banking. We have come close before and the hope to disappoint cycle layers on top of the industry’s challenges have lessened the morale.

Let the record show that this is a generational opportunity, the ability to be a part of an economy that could likely disrupt all industries, pharma, tobacco, alcohol, CPG, etc.

Every step forward leads to five steps back, which is tedious and exhausting, but eventually, you’ll come across a tiny glimmer of hope that reminds you of why you are here, and inspires you to keep moving forward.

The thesis is the same.

Stay on the path it’s still happening.

The visual, by Jack Butcher, sums it up beautifully.

This may feel pointless, but we may just be one step away from a true breakthrough.

Editors’ Note: This is an excerpt from our Monthly Playbook. If you would like to read the full monthly playbook and join the thousands of others you can sign up below.

Share and Enjoy !

laptop-img
Get In touch With Us

Action-Oriented problem solvers ready to go

One Report Once a Month Everything you Need to know

From executive-level strategy to technical know-how, our actionable insights keep you ahead of the pack!

The Chairman of Cannabis

On the call when the CRC announced TerrAscend was awarded a New Jersey Cannabis license:

On that call, it was interesting. They had already gone through the other six operators that they approved. And the process was, I believe, that the chairman would state the name of the operator and say, buy, have a motion to approve. Then somebody would come on, which other commissioner, and would say a motion to approve and then they would vote. And then they got to TerrAscend.

We felt really good about getting approved, even if it was a smaller number than the seven that ended up getting there. The chairwoman said, ‘do I have a motion to approve?’, and nobody said anything. It felt to me like everything froze. I went through all these emotions. I thought, ‘did my line just die?’ I wanted somebody to jump in and say something, but then it meant that, at some point, if they said something, then it meant that it wasn’t just my phone that died, which I was almost hoping for that.

All of that happened in ten seconds or so. Then the chairwoman repeated it. And somebody came on and said, ‘I make a motion.’

On why NJ is a key state for TerrAscend:

New Jersey will be a huge driver of our business one year from now. Hopefully, we have three stores that are rating in Jersey at over $40 million in re. And, we should have a strong wholesale business selling to the other operators in the state as well.

We will have finished our expansion in New Jersey in terms of our cultivation expansion, where we’re going to double our footprint. So that’ll be in Jersey, and Maryland rec will have started or be about to start. We’ll have completed that facility and be fully ready to be one of the top players there in that market, and Pennsylvania will be ready for rec as well.

We have three huge drivers coming up. Gage will be much larger than it is now. There are some amazing deals out there for small to buy small mom-and-pop dispensaries for low single-digit EBITDA multiples. So, we’ll go from seventeen dispensaries right now to closer to thirty or so.

Jason Wild, Chairman of TerrAscend

On strategy differences from TerrAscend and other large MSOS:

We wanted to go deep into that. We don’t have a big footprint. And New Jersey, where we aim to be one of the top one or two players, has so much more of an impact on our numbers and we’re so much more leveraged to Jersey than all of the other operators.

I have definitely, even after the approval, been focusing a ton of my time and attention there. When being in this business, you have to keep a lot of balls in the air and certainly Maryland. We are building a large-scale facility down there that should be operational at least in the late summer of this year and hopefully rec will be on the ballot in Maryland. It looks like it will be. So that could be a state that turns a rec, say, sometime next year.

In Pennsylvania, where we have our largest power facility, there is a lot of talk that it will be going rec next year as well, that’ll be done legislatively — because I think they can’t do it with ballot.

*** The following transcript is AI generated and some words have been removed for spacing. Please listen to the epsiode for full context.


Emily Paxhia, Managing Director Posiedon

*** The following transcript is AI generated and some words have been removed for spacing. Please listen to the epsiode for full context.

Harnessing The Green Wave

On when they first started investing in cannabis:

Back when we first started investing in cannabis, there were other firms that started to pop up and they would invest in cannabis, but they wouldn’t do “plant-touching operators”. We would actually invest in plant-touching operators because we couldn’t ignore the business potential of these companies.

Now we all know because we hear the earnings calls and see the reports that come out of these operators. And when you’re looking at gross margins, some of these companies are in the 60% and you’re looking at EBITDA margins above 30%. These are very interesting business profiles, and they are experiencing massive growth year over year.

So, it’s interesting how these limitations actually create opportunities when you pay attention.

On how Poseidon brings a value-added approach to the companies they invest in:

We don’t just typically write checks.

Although sometimes you just have to know where your attention is best received. Sometimes when you do invest in a company, they’re not as interested in having an active investor at the table. If they’re running their business as well, we tend to just say, ‘you’re good to go.’ But a lot of times we are actively involved, and it’s something we set as an expectation at the outset of the investment for our founders — that we’re here.

We’re partners. At the beginning of the pandemic, we had an all-hands meeting for the entire portfolio and brought on insurance people, lawyers, accountants, just everything. Everybody had resources at hand for what appeared to be a Black Swan event, as Sequoia Capital called it.

On why Posiedon invested in Juul:

They were doing the razor blade model, which is that they were going to be able to work with partners.

They weren’t going to take on the capital-intensive aspect of cultivating processing and infusing the pods themselves. They were going to work with some of these well-known brands like “Jetty extracts” in order to do it. The razor blade model is great because it’s a light touch, then you have a pretty strong impact and a great brand experience.

Editors’ Note: This is an excerpt from our Monthly Playbook. If you would like to read the full monthly playbook and join the thousands of others you can sign up below.

Share and Enjoy !

laptop-img
Get In touch With Us

Action-Oriented problem solvers ready to go

One Report Once a Month Everything you Need to know

From executive-level strategy to technical know-how, our actionable insights keep you ahead of the pack!

The Fyllo Regulatory Database creates unparalleled visibility at every level of government, with access to more than 4,300 sources in 1,450+ jurisdictions across the country. Today’s leading MSOs, SSOs and law firms rely on Fyllo to accelerate research, track licensing opportunities and make better decisions. To learn more or schedule a demo, please visit hellofyllo.com.

Multiple groups of advocates are working to collect signatures to place recreational cannabis on the November ballot. Arkansas voters already approved medical cannabis use in 2016 and the first dispensaries opened in 2019. Responsible Growth Arkansas has put forward the Arkansas Adult-Use Cannabis Amendment, which would expand the current medical system to include a recreational industry. Competitors to that proposal, Arkansas True Grass, are hoping to submit their own Recreational Cannabis Amendment, which includes unlimited license caps, but no decriminalization language. Both groups must submit approximately 89,000 signatures by July 2022 in order to be considered for the ballot

Editors’ Note: This is an excerpt from our Monthly Playbook. If you would like to read the full monthly playbook and join the thousands of others you can sign up below.

Share and Enjoy !

laptop-img
Get In touch With Us

Action-Oriented problem solvers ready to go

One Report Once a Month Everything you Need to know

From executive-level strategy to technical know-how, our actionable insights keep you ahead of the pack!